ABSTRACT
Thrombolytic therapy for stroke with the introduction of tissue plasminogen activator (t-PA) was a boon to stroke physicians, since it meant that morbidity and mortality could be reduced with the optimal use of t-PA. The editor and his well-respected contributors offer the reader their personal perspectives on the evidence-based use of various thrombolytic and anti-thrombotic agents that are available and that can provide successful outcomes. Thrombolytic and Antithrombotic Therapy for Stroke is updated and thoroughly referenced. Everyone working in the casualty/emergency room must read this clearly-written text.
TABLE OF CONTENTS
chapter 1|12 pages
Thrombosis and therapeutic antidotes: historical aspects
Louis R Caplan Thrombosis takes center stage
chapter 2|8 pages
Antithrombotic drugs: anticoagulants (heparins)
Ángel Chamorro Unfractionated heparin (UFH)
chapter 6|16 pages
Thrombolytic/antithrombotic clinical trials in cardiology: an overview
Daniel Jenni and Jürg-Hans Beer
chapter 11|10 pages
New antithrombotics and their potential use
Patrik Michel Thrombosis and antithrombotics in acute stroke: current knowledge
chapter 13|10 pages
Thrombolytic therapy for acute stroke: the studies
Peter D Schellinger, Jochen B Fiebach, and Peter A Ringleb
chapter 15|12 pages
Implementation of thrombolytic therapy for stroke in routine practice
Guntram W Ickenstein, Heinrich J Audebert, and Nils Gunnar Wahlgren
chapter 18|10 pages
Intra-arterial thrombolysis for acute ischemic stroke
Anthony J Furlan and Herman Zeumer Intra-arterial thrombolysis
chapter 19|20 pages
Various combined approaches: present and future
Danilo Toni, Svetlana Lorenzano, Romesh Markus, and Geoffrey Donnan intra-arterial thrombolysis